Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

FIVE PRIME THERAPEUTICS, INC. (FPRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2022 SC 13G/A Rock Springs Capital Management LP reports a 0% stake in Five Prime Therapeutics, Inc.
05/17/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
04/26/2021 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
04/22/2021 EFFECT Form EFFECT - Notice of Effectiveness:
04/16/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/16/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/16/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/16/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/16/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/16/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/16/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/16/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
04/16/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
04/16/2021 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
04/16/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
04/16/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/16/2021 8-K Resignation/termination of a director
Docs: "Tenth Amended and Restated Certificate of Incorporation of Five Prime Therapeutics, Inc.",
"Amended and Restated Bylaws of Five Prime Therapeutics, Inc.",
"Form of Gross-Up Agreement"
04/15/2021 8-K Other Events  Interactive Data
04/08/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/08/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
04/06/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
04/06/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
03/22/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/22/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
03/22/2021 10-K Annual Report for the period ended December 31, 2020
03/18/2021 GN SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of FRTA, AEGN, FPRX, and MIK Buyouts
03/18/2021 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
03/18/2021 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
03/15/2021 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
03/08/2021 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
03/08/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
03/08/2021 GN INVESTIGATION ALERT: Halper Sadeh LLP Investigates SVBI, FPRX, MIK, JCS; Shareholders Are Encouraged to Contact the Firm
03/05/2021 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
03/05/2021 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy